Back
Inhibrx Biosciences Stock Price Chart
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
42
INBX
Inhibrx Biosciences
Last Price:
$12.26
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is relatively stagnant and INBX is experiencing slight buying pressure.
Inhibrx Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.46 | Buy |
| 20-day SMA: | 11.85 | Buy |
| 50-day SMA: | 12.73 | Sell |
| 200-day SMA: | 14.01 | Sell |
| 8-day EMA: | 11.73 | Buy |
| 20-day EMA: | 11.88 | Buy |
| 50-day EMA: | 12.42 | Sell |
| 200-day EMA: | 13.75 | Sell |
Inhibrx Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.24 | Sell |
| Relative Strength Index (14 RSI): | 53 | Buy |
| Chaikin Money Flow: | 18902 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.35 - 12.27) | Buy |
| Bollinger Bands (100): | (11.97 - 14.35) | Sell |
Inhibrx Biosciences Technical Analysis
| May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Inhibrx Biosciences Stock
Is Inhibrx Biosciences Stock a Buy?
-
Inhibrx Biosciences share price is 12.33 while INBX 8-day simple moving average is 11.46, which is a Buy signal.
-
The stock price of INBX is 12.33 while Inhibrx Biosciences 20-day SMA is 11.85, which makes it a Buy.
-
Inhibrx Biosciences 50-day simple moving average is 12.73 while INBX share price is 12.33, making it a Sell technically.
-
INBX stock price is 12.33 and Inhibrx Biosciences 200-day simple moving average is 14.01, creating a Sell signal.
INBX Technical Analysis vs Fundamental Analysis
Sell
42
Inhibrx Biosciences (INBX)
is a Sell
Is Inhibrx Biosciences a Buy or a Sell?
-
Inhibrx Biosciences stock is rated a SellThe current Inhibrx Biosciences [INBX] share price is $12.33. The Score for INBX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Inhibrx Biosciences Stock Info
Market Cap:
178.5M
Price in USD:
12.33
Share Volume:
54.7K
Inhibrx Biosciences 52-Week Range
52-Week High:
18.95
52-Week Low:
10.80
Sell
42
Inhibrx Biosciences (INBX)
is a Sell
Inhibrx Biosciences Share Price Forecast
-
What is the Inhibrx Biosciences stock price today?The Inhibrx Biosciences stock price is 12.33 USD today.
-
Will INBX stock go up or go down?Inhibrx Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Inhibrx Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Inhibrx Biosciences is overvalued.
Is Inhibrx Biosciences Stock a Buy?
-
Inhibrx Biosciences share price is 12.33 while INBX 8-day exponential moving average is 11.73, which is a Buy signal.
-
The stock price of INBX is 12.33 while Inhibrx Biosciences 20-day EMA is 11.88, which makes it a Buy.
-
Inhibrx Biosciences 50-day exponential moving average is 12.42 while INBX share price is 12.33, making it a Sell technically.
-
INBX stock price is 12.33 and Inhibrx Biosciences 200-day simple moving average is 13.75, creating a Sell signal.
Fundamental Analysis of Inhibrx Biosciences
Is Inhibrx Biosciences a good investment?
-
Analysts estimate an earnings decrease this quarter of $1.05 per share, an increase next quarter of $0.26 per share, a decrease this year of $122.34 per share, and an increase next year of $0.76 per share.
Technical Analysis of Inhibrx Biosciences
Should I short Inhibrx Biosciences stock?
-
INBX Moving Average Covergence Divergence (MACD) indicator is -0.24, suggesting Inhibrx Biosciences is a Sell
-
Inhibrx Biosciences Relative Strength Index (RSI) is 53, which suggest Inhibrx Biosciences is overbought
-
The Bollinger Bands (25) for Inhibrx Biosciences is (11.35 - 12.27), which suggest Inhibrx Biosciences is a Sell
-
The Bollinger Bands (100) for Inhibrx Biosciences is (11.97 - 14.35), which suggest Inhibrx Biosciences is a Sell
* Inhibrx Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.